These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 28384481)

  • 41. Dopamine-related dissociation of cortical and subcortical brain activations in cognitively unimpaired Parkinson's disease patients OFF and ON medications.
    Kim J; Zhang K; Cai W; YorkWilliams S; Ua Cruadhlaoich MAI; Llanes S; Menon V; Poston KL
    Neuropsychologia; 2018 Oct; 119():24-33. PubMed ID: 30040957
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of dopamine and clinical heterogeneity in cognitive dysfunction in Parkinson's disease.
    Cools R; Tichelaar JG; Helmich RCG; Bloem BR; Esselink RAJ; Smulders K; Timmer MHM
    Prog Brain Res; 2022; 269(1):309-343. PubMed ID: 35248200
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cognitive executive impairment and dopaminergic deficits in de novo Parkinson's disease.
    Siepel FJ; Brønnick KS; Booij J; Ravina BM; Lebedev AV; Pereira JB; Grüner R; Aarsland D
    Mov Disord; 2014 Dec; 29(14):1802-8. PubMed ID: 25284687
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of asymmetric dopamine depletion on sensitivity to rewarding and aversive stimuli in Parkinson's disease.
    Maril S; Hassin-Baer S; Cohen OS; Tomer R
    Neuropsychologia; 2013 Apr; 51(5):818-24. PubMed ID: 23422331
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Are dopaminergic pathways involved in theory of mind? A study in Parkinson's disease.
    Péron J; Vicente S; Leray E; Drapier S; Drapier D; Cohen R; Biseul I; Rouaud T; Le Jeune F; Sauleau P; Vérin M
    Neuropsychologia; 2009 Jan; 47(2):406-14. PubMed ID: 18845171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of dopamine on reinforcement learning and consolidation in Parkinson's disease.
    Grogan JP; Tsivos D; Smith L; Knight BE; Bogacz R; Whone A; Coulthard EJ
    Elife; 2017 Jul; 6():. PubMed ID: 28691905
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of dopaminergic medication on conflict adaptation in Parkinson's disease.
    Ruitenberg MFL; Abrahamse EL; Santens P; Notebaert W
    J Neuropsychol; 2019 Mar; 13(1):121-135. PubMed ID: 28714199
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dopaminergic drugs modulate learning rates and perseveration in Parkinson's patients in a dynamic foraging task.
    Rutledge RB; Lazzaro SC; Lau B; Myers CE; Gluck MA; Glimcher PW
    J Neurosci; 2009 Dec; 29(48):15104-14. PubMed ID: 19955362
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients.
    Bódi N; Kéri S; Nagy H; Moustafa A; Myers CE; Daw N; Dibó G; Takáts A; Bereczki D; Gluck MA
    Brain; 2009 Sep; 132(Pt 9):2385-95. PubMed ID: 19416950
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reward sensitivity deficits modulated by dopamine are associated with apathy in Parkinson's disease.
    Muhammed K; Manohar S; Ben Yehuda M; Chong TT; Tofaris G; Lennox G; Bogdanovic M; Hu M; Husain M
    Brain; 2016 Oct; 139(Pt 10):2706-2721. PubMed ID: 27452600
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dopaminergic modulation of novelty repetition in Parkinson's disease: A study of P3 event-related brain potentials.
    Bertram M; Warren CV; Lange F; Seer C; Steinke A; Wegner F; Schrader C; Dressler D; Dengler R; Kopp B
    Clin Neurophysiol; 2020 Dec; 131(12):2841-2850. PubMed ID: 33137574
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dopamine depletion alters macroscopic network dynamics in Parkinson's disease.
    Shine JM; Bell PT; Matar E; Poldrack RA; Lewis SJG; Halliday GM; O'Callaghan C
    Brain; 2019 Apr; 142(4):1024-1034. PubMed ID: 30887035
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dopaminergic modulation of motor network dynamics in Parkinson's disease.
    Michely J; Volz LJ; Barbe MT; Hoffstaedter F; Viswanathan S; Timmermann L; Eickhoff SB; Fink GR; Grefkes C
    Brain; 2015 Mar; 138(Pt 3):664-78. PubMed ID: 25567321
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dopaminergic medication alters auditory distractor processing in Parkinson's disease.
    Georgiev D; Jahanshahi M; Dreo J; Čuš A; Pirtošek Z; Repovš G
    Acta Psychol (Amst); 2015 Mar; 156():45-56. PubMed ID: 25697781
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A dopaminergic basis for working memory, learning and attentional shifting in Parkinsonism.
    Moustafa AA; Sherman SJ; Frank MJ
    Neuropsychologia; 2008 Nov; 46(13):3144-56. PubMed ID: 18687347
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential effects of dopaminergic medication on basic motor performance and executive functions in Parkinson's disease.
    Michely J; Barbe MT; Hoffstaedter F; Timmermann L; Eickhoff SB; Fink GR; Grefkes C
    Neuropsychologia; 2012 Aug; 50(10):2506-14. PubMed ID: 22776611
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sequence learning in Parkinson's disease: Focusing on action dynamics and the role of dopaminergic medication.
    Ruitenberg MFL; Duthoo W; Santens P; Seidler RD; Notebaert W; Abrahamse EL
    Neuropsychologia; 2016 Dec; 93(Pt A):30-39. PubMed ID: 27702597
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of acute tryptophan depletion on cognition, memory and motor performance in Parkinson's disease.
    Scholtissen B; Verhey FR; Adam JJ; Prickaerts J; Leentjens AF
    J Neurol Sci; 2006 Oct; 248(1-2):259-65. PubMed ID: 16756999
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dopaminergic modulation of the planning phase of skill acquisition in Parkinson's disease.
    Hanna-Pladdy B; Heilman KM
    Neurocase; 2010 Apr; 16(2):182-90. PubMed ID: 20013480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. On the role of dopamine replacement therapy in decision-making, working memory, and reward in Parkinson's disease: does the therapy-dose matter?
    Torta DM; Castelli L; Zibetti M; Lopiano L; Geminiani G
    Brain Cogn; 2009 Nov; 71(2):84-91. PubMed ID: 19442427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.